Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Steve Udvarhelyi, CEO of Blue Cross, to retire; successor announced | Business Update

Reading Time: < 1 minute

Blue Cross and Blue Shield of Louisiana CEO Dr. Steve Udvarhelyi has announced his retirement after more than eight years at the helm of the company. This comes after the controversial and ultimately unsuccessful attempt to sell the nonprofit to Elevance Health. Executive Vice President and Chief Operating Officer Bryan Camerlinck has been chosen to succeed Udvarhelyi and will take over immediately.

The decision to retire follows the shelving of the proposed sale to Elevance, which faced opposition from doctors, hospitals, policyholders, and state lawmakers. Despite Udvarhelyi’s efforts to convince stakeholders of the benefits of the deal, concerns about regulatory issues and political influence led to the deal being tabled.

During his tenure, Udvarhelyi helped turn around the company’s financial situation, increasing reserves by 38% to $1.65 billion in 2022. He also diversified Blue Cross offerings into government-sponsored plans like Medicare and Medicaid. However, the company’s traditional employer-sponsored health plans saw a decline as customers sought ways to save on healthcare costs.

Camerlinck, who joined Blue Cross in 2016 and was promoted to COO in 2021, brings over 20 years of experience in the industry. He expressed his commitment to continuing the company’s mission of providing top-tier service to its members.

The retirement of Udvarhelyi marks a new chapter for Blue Cross and Blue Shield of Louisiana, as Camerlinck takes on the role of leading the company through the evolving healthcare landscape. The transition comes at a critical time for the organization as it navigates challenges and opportunities in the industry.

Taylor Swifts New Album Release Health issues from using ACs Boston Marathon 2024 15 Practical Ways To Save Money